SEC Form 4 · accession 0001246360-17-000885
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph E Turk Jr.
Officer — President
Period of report
Feb 17, 2017
Accepted (ET)
Feb 21, 2017 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 17, 2017 | M | 6,000 | $14.66 | A | 75,280 | D | |
| Common Stock | Feb 17, 2017 | S | 6,000 | $29.66 | D | 69,280 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $14.66 | Feb 17, 2017 | M | 6,000 | D | Apr 10, 2014 | Mar 9, 2024 | Common Stock | 6,000 | 48,958 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016.